Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks
NASDAQ:NRXS

NeurAxis 11/20/2023 Earnings Report

NeurAxis logo
$2.54 +0.06 (+2.42%)
Closing price 03:59 PM Eastern
Extended Trading
$2.52 -0.02 (-0.59%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
ProfileEarnings HistoryForecast

NeurAxis EPS Results

Actual EPS
-$1.06
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

NeurAxis Revenue Results

Actual Revenue
$0.48 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

NeurAxis Announcement Details

Quarter
Date
11/20/2023
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

NeurAxis Earnings Headlines

Short Interest in NeurAxis, Inc. (NASDAQ:NRXS) Grows By 85.6%
August 20, 2025  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30287573
NeurAxis, Inc. Reports Robust Q2 2025 Growth
August 13, 2025  |  msn.comhttps://www.msn.com/en-us/money/technology/neuraxis-inc-reports-robust-q2-2025-growth/ar-AA1KqLxi
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.tc pixel
August 29 at 2:00 AM  |  Brownstone Research (Ad)
Neuraxis reports Q2 EPS (22c) vs. (42c) last year
August 12, 2025  |  msn.comhttps://www.msn.com/en-us/money/other/neuraxis-reports-q2-eps-22c-vs-42c-last-year/ar-AA1KnFXw
NeurAxis, Inc. (NRXS) Q2 2025 Earnings Call Transcript
August 12, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4812693-neuraxis-inc-nrxs-q2-2025-earnings-call-transcript
Earnings Outlook For Neuraxis
August 11, 2025  |  benzinga.comhttps://www.benzinga.com/insights/earnings/25/08/47040047/earnings-outlook-for-neuraxis
See More NeurAxis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NeurAxis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NeurAxis and other key companies, straight to your email.

About NeurAxis

NeurAxis (NASDAQ:NRXS), a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

View NeurAxis Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles